News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Final GOP Tax Bill Won’t Ding Graduate Students
Shawna Williams | Dec 14, 2017
A provision to tax tuition waivers was dropped during the reconciliation process.
Two Dozen House Republicans Do an About-Face on Tuition Tax
Diana Kwon | Dec 7, 2017
The proposed tax on graduate tuition waivers would significantly increase students’ taxable income.
Opinion: Taxable Tuition = Trouble for Graduate Students
Patricia M. Lawston, Michael T. Parker | Nov 30, 2017
Our calculations find troubling increases in taxes if a US House–led tax plan succeeds, but tuition waivers, as the Senate bill has proposed, could actually reduce students’ tax burdens.
Republican Tax Plan Eliminates Popular Education Exemptions
Shawna Williams | Nov 6, 2017
The proposal draws criticism from higher-education groups.
Shire to Buy Baxalta for $32 Billion
Tracy Vence | Jan 12, 2016
The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.
AbbVie Buys Shire for $54 Billion
Bob Grant | Jul 21, 2014
The massive pharma deal will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.
Smoking, Taxes, and Genes
Bob Grant | Dec 14, 2012
New research suggests that some smokers may carry a gene variant that makes them less likely to quit simply because cigarette taxes are raised.